Effects of 6-mercaptopurine (6-MP) on histomorphometric parameters of the rat bones.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 4
Abstract
6-Mercaptopurine (6-MP) is an antimetabolite. The drug inhibits DNAsynthesis of cells by acting as a false analog of purines. 6-MP displays a cytostatic and immunosuppressive activity. The studies carried out so far focus mostly on recognizing the clinical effectiveness of 6-MP, particularly in treating autoimmune diseases, whereas its effect on the osseous tissue still remains unknown. We examined the effect of 6-MP on the osseous system in rats after a 4-week period of its administration by analyzing histomorphometric parameters and bone mass, mineral and calcium content. We also tested the reversal of the above changes after the lapse of 4 week-period during which 6-MP was not administered. Male Wistar rats were divided into 6 groups, each group was composed of 8 animals. Treatment of 6-MP started on day 2 of the experiment, and the drug was administered for 28 days, i.e. between day 2 and 29 in all groups examined. Changes in the histomorphometric parameters were examined in 3 groups 4 weeks after the first 6-MP or 0.9% NaCl administration: I - control group (0.9% NaCl solution), II - 6MP group (6-MP at the dose of 2.5 mg/kg po), III - 6-MPgroup (6-MP at the dose of 5 mg/kg po). Reversal of the changes was examined 8 weeks after the first 6-MP or 0.9% NaCl administration in 3 groups: IV - control group (0.9% NaCl solution), V - 6-MP group (6-MP at the dose of 2.5 mg/kg po), VI - 6-MP group (6MP at the dose of 5 mg/kg po). We demonstrated that 6-MP administered orally at a dose of 2.5 mg/kg po or at a dose of 5 mg/kg po for the period of 4 weeks inhibited the synthesis and mineralization of the osseous tissue by causing a disorder in histomorphometric parameters, which were not totally reversed after 4 weeks. 6-MP administered at a dose of 5 mg/kg also caused a reduction of mineral and calcium content, mostly in the cancellous bone, which returned to normal after 4 weeks.
Authors and Affiliations
Urszula Cegieła, Ilona Kaczmarczyk-Sedlak, Leszek Śliwiński, Barbara Nowińska
Keywords
Related Articles
- EP ID EP159752
- DOI -
- Views 92
- Downloads 0
Antioxidant treatment normalizes renal Na(+),K(+)-ATPase activity in leptin-treated rats.
Hyperleptinemia may be involved in the pathogenesis of obesity-associated hypertension, however, the mechanism of hypertensive effect of leptin is incompletely elucidated. Previously, we have demonstrated that chronic hy...
Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation.
Endothelial dysfunction, which is defined by decreased endothelium-dependent vasodilatation, is associated with an increased number of cardiovascular events. Nitric oxide (NO) bioavailability is reduced by altered endoth...
Involvement of adenosine receptor agonists on the development of hypersensitivity to acute dose of morphine during morphine withdrawal period.
In the present study, the involvement of the selective adenosine A(1) (CPA) and A(2A) (CGS 21680) and non-selective adenosine A(1)/A(2A) (NECA) receptor agonists on the development of hypersensitivity to acute morphine i...
Effects of acute and chronic treatment with magnesium in the forced swim test in rats.
The antidepressant-like activity of magnesium, the non-specific N-methyl-D-aspartate glutamate receptor antagonist, in the mice forced swim test was demonstrated previously. In the present study, the effects of this biom...
Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients.
Digoxin, a drug of narrow therapeutic index, is a substrate for common transmembrane transporter, P-glycoprotein, encoded by ABCB1 (MDR1) gene. It has been suggested that ABCB1 polymorphism, as well as co-administration...